Holst J
J Physiol. 2024; 602(24):6613-6629.
PMID: 39520693
PMC: 11649525.
DOI: 10.1113/JP287461.
Hope D, Vincent M, Tan T
Front Endocrinol (Lausanne). 2021; 12:735019.
PMID: 34566894
PMC: 8457634.
DOI: 10.3389/fendo.2021.735019.
Conlon J
Front Endocrinol (Lausanne). 2021; 12:683089.
PMID: 34177808
PMC: 8226317.
DOI: 10.3389/fendo.2021.683089.
Lafferty R, Oharte F, Irwin N, Gault V, Flatt P
Front Endocrinol (Lausanne). 2021; 12:689678.
PMID: 34093449
PMC: 8171296.
DOI: 10.3389/fendo.2021.689678.
Muller T, Finan B, Bloom S, DAlessio D, Drucker D, Flatt P
Mol Metab. 2019; 30:72-130.
PMID: 31767182
PMC: 6812410.
DOI: 10.1016/j.molmet.2019.09.010.
Methods and Guidelines for Measurement of Glucagon in Plasma.
Holst J, Wewer Albrechtsen N
Int J Mol Sci. 2019; 20(21).
PMID: 31671667
PMC: 6862148.
DOI: 10.3390/ijms20215416.
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy.
Holst J
Front Endocrinol (Lausanne). 2019; 10:260.
PMID: 31080438
PMC: 6497767.
DOI: 10.3389/fendo.2019.00260.
Unraveling oxyntomodulin, GLP1's enigmatic brother.
Pocai A
J Endocrinol. 2012; 215(3):335-46.
PMID: 23019069
PMC: 3493657.
DOI: 10.1530/JOE-12-0368.
Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes.
Chiba M, Sanada Y, Kawano S, Murofushi M, Okada I, Yoshizawa Y
Pediatr Surg Int. 2007; 23(6):551-4.
PMID: 17333210
DOI: 10.1007/s00383-007-1895-9.
Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro.
Myojo S, Tsujikawa T, Sasaki M, Fujiyama Y, Bamba T
J Gastroenterol. 1997; 32(3):300-5.
PMID: 9213241
DOI: 10.1007/BF02934484.
Glucagon-, glicentin-, and pancreatic polypeptide-like immunoreativities in rectal carcinoids and related colorectal cells.
Fiocca R, Capella C, Buffa R, Fontana R, Solcia E, Hage E
Am J Pathol. 1980; 100(1):81-92.
PMID: 7395969
PMC: 1903769.
Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.
Holst J
Biochem J. 1982; 207(3):381-8.
PMID: 7165698
PMC: 1153876.
DOI: 10.1042/bj2070381.
Glucagon- and glicentin-immunoreactive cells in the human digestive tract.
Garaud J, Eloy R, Moody A, Stock C, GRENIER J
Cell Tissue Res. 1980; 213(1):121-36.
PMID: 7006827
DOI: 10.1007/BF00236925.
Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses.
Jenkins D, Bloom S, Albuquerque R, Leeds A, Sarson D, Metz G
Gut. 1980; 21(7):574-9.
PMID: 7000630
PMC: 1419882.
DOI: 10.1136/gut.21.7.574.
A pancreatic polypeptide (PP)-like immunoreactant is present in the glicentin-containing cell of the cat intestine.
Ravazzola M, Orci L
Histochemistry. 1980; 67(2):221-4.
PMID: 6995410
DOI: 10.1007/BF00493239.
Identification and localization of glucagon-related peptides in rat brain.
Tager H, Hohenboken M, Markese J, Dinerstein R
Proc Natl Acad Sci U S A. 1980; 77(10):6229-33.
PMID: 6934548
PMC: 350249.
DOI: 10.1073/pnas.77.10.6229.
Evidence that glicentin contains the entire sequence of glucagon.
Holst J
Biochem J. 1980; 187(2):337-43.
PMID: 6893148
PMC: 1161798.
DOI: 10.1042/bj1870337.
The glucagon-like polypeptides - order out of chaos?.
Conlon J
Diabetologia. 1980; 18(2):85-8.
PMID: 6892701
DOI: 10.1007/BF00290482.
Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach.
Ito H, Yokozaki H, Hata J, Mandai K, Tahara E
Virchows Arch A Pathol Anat Histopathol. 1984; 404(1):17-29.
PMID: 6433545
DOI: 10.1007/BF00704247.
Insulin and glucagon in spontaneously diabetic non-obese mice.
OHNEDA A, Kobayashi T, Nihei J, Tochino Y, Kanaya H, Makino S
Diabetologia. 1984; 27(4):460-3.
PMID: 6391989
DOI: 10.1007/BF00273911.